@article{MTMT:34534149,
	title = {Diagnostic value of [ 99m Tc]Tc-PSMA-I&S-SPECT/CT for the primary staging and restaging of prostate cancer},
	url = {https://m2.mtmt.hu/api/publication/34534149},
	author = {Farkas, István and Sipka, Gábor and Bakos, Annamária and Maráz, Anikó and Bajory, Zoltán and Mikó, Zsófia Sára and Czékus, Tamás and Urbán, Szabolcs and Varga, Linda and Pávics, László and Besenyi, Zsuzsanna},
	doi = {10.1177/17588359231221342},
	journal-iso = {THER ADV MED ONCOL},
	journal = {THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY},
	volume = {16},
	unique-id = {34534149},
	issn = {1758-8340},
	year = {2024},
	eissn = {1758-8359},
	orcid-numbers = {Farkas, István/0000-0002-0270-7101; Sipka, Gábor/0000-0002-1259-0576; Bakos, Annamária/0000-0003-2235-9754; Maráz, Anikó/0000-0002-2018-8413; Bajory, Zoltán/0000-0003-3835-2549; Mikó, Zsófia Sára/0000-0001-6293-6451; Czékus, Tamás/0000-0001-7612-4905; Urbán, Szabolcs/0000-0001-5463-6811; Varga, Linda/0000-0003-4116-9497; Pávics, László/0000-0002-7319-1667; Besenyi, Zsuzsanna/0000-0001-9115-9620}
}

@article{MTMT:34408957,
	title = {A vesesejtes karcinóma gyógyszeres terápiája},
	url = {https://m2.mtmt.hu/api/publication/34408957},
	author = {Rozsvai, Tímea and Maráz, Anikó},
	journal-iso = {ONKOLÓGIA & HEMATOLÓGIA},
	journal = {ONKOLÓGIA & HEMATOLÓGIA: AZ ONCOLOGY FOLYÓIRAT MAGYAR NYELVŰ KIADÁSA},
	volume = {14},
	unique-id = {34408957},
	issn = {2559-8066},
	year = {2024},
	pages = {9-12},
	orcid-numbers = {Maráz, Anikó/0000-0002-2018-8413}
}

@article{MTMT:34443972,
	title = {A vesekarcinóma legújabb kezelési lehetőségei},
	url = {https://m2.mtmt.hu/api/publication/34443972},
	author = {Rozsvai, Tímea and Varga, Linda and Maráz, Anikó},
	journal-iso = {ONKOLÓGIA & HEMATOLÓGIA},
	journal = {ONKOLÓGIA & HEMATOLÓGIA: AZ ONCOLOGY FOLYÓIRAT MAGYAR NYELVŰ KIADÁSA},
	volume = {13},
	unique-id = {34443972},
	issn = {2559-8066},
	year = {2023},
	pages = {300-306},
	orcid-numbers = {Varga, Linda/0000-0003-4116-9497; Maráz, Anikó/0000-0002-2018-8413}
}

@{MTMT:34426094,
	title = {Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy},
	url = {https://m2.mtmt.hu/api/publication/34426094},
	author = {Paszt, Attila and Simonka, Zsolt and Budai, Krisztina and Horváth, Zoltán and Erdos, Marton and Vas, Márton Árpád and Ottlakán, Aurél and Nyári, Tibor András and Szepes, Zoltán and Uhercsák, Gabriella and Maráz, Anikó and Torday, László and Tiszlavicz, László and Oláh, Judit Magdolna and Lázár, György ifj},
	booktitle = {Surgical and Oncological Updates in the Management of Gastric Cancer: the Role of Neoadjuvant Therapy and Minimally Invasive Surgery},
	unique-id = {34426094},
	year = {2023},
	pages = {56-68},
	orcid-numbers = {Paszt, Attila/0000-0002-1637-8652; Simonka, Zsolt/0000-0002-3490-226X; Horváth, Zoltán/0000-0002-9790-4975; Ottlakán, Aurél/0000-0002-7743-7775; Nyári, Tibor András/0000-0001-8900-6641; Szepes, Zoltán/0000-0002-9466-8719; Maráz, Anikó/0000-0002-2018-8413; Torday, László/0000-0002-2911-5499; Tiszlavicz, László/0000-0003-1134-6587; Lázár, György ifj/0000-0001-7155-2978}
}

@misc{MTMT:34397846,
	title = {Versengő terápiák. Metasztatikus hormonszenzitív prosztata daganat},
	url = {https://m2.mtmt.hu/api/publication/34397846},
	author = {Ágoston, Péter Zoltán and Géczi, Lajos and Bíró, Krisztina and Küronya, Zsófia and Lakosi, Ferenc and Maráz, Anikó},
	unique-id = {34397846},
	year = {2023},
	orcid-numbers = {Ágoston, Péter Zoltán/0000-0003-0264-630X; Géczi, Lajos/0000-0001-7432-2043; Bíró, Krisztina/0000-0002-2070-0608; Maráz, Anikó/0000-0002-2018-8413}
}

@article{MTMT:34344590,
	title = {A magyar daganatos betegek túlélési esélyei nemzetközi tükörben},
	url = {https://m2.mtmt.hu/api/publication/34344590},
	author = {Vokó, Zoltán and Polgár, Csaba and Nagy, Péter and Szabó, G Tamás and Horváth, Zsolt and Wittmann, István and Molnár, Gergő Attila and Gyöngyösi, Eszter and Rokszin, György Aurél and Fábián, Ibolya and Kovács, Valéria and Abonyi-Tóth, Zsolt and Kenessey, István and Wéber, András and Branyiczkiné, Géczy Gabriella and Hilbert, Lászlóné and Bartókné, Tamás Renáta and Surján, György and Barcza, Zsófia and Gálffy, Gabriella and Bogos, Krisztina and Moldvay, Judit and Tamási, Lilla and Krasznai, Zoárd and Ostoros, Gyula and Pápai-Székely, Zsolt and Maráz, Anikó and Kiss, Zoltán},
	journal-iso = {MAGYAR ONKOLÓGIA},
	journal = {MAGYAR ONKOLÓGIA},
	volume = {67},
	unique-id = {34344590},
	issn = {0025-0244},
	year = {2023},
	eissn = {2060-0399},
	pages = {62-62},
	orcid-numbers = {Polgár, Csaba/0000-0001-7245-0762; Nagy, Péter/0000-0003-3393-235X; Abonyi-Tóth, Zsolt/0000-0002-5585-3313; Kenessey, István/0000-0002-6963-8489; Wéber, András/0000-0003-1605-8226; Maráz, Anikó/0000-0002-2018-8413}
}

@article{MTMT:34343530,
	title = {Az új NEAK-EMK rendszer a szakmai bíráló és a kezelőorvos szemszögéből, avagy a „Jó, a Rossz és a Csúf” döntési mechanizmusok},
	url = {https://m2.mtmt.hu/api/publication/34343530},
	author = {Mangel, László Csaba and Maráz, Anikó and Géczi, Lajos},
	journal-iso = {MAGYAR ONKOLÓGIA},
	journal = {MAGYAR ONKOLÓGIA},
	volume = {67},
	unique-id = {34343530},
	issn = {0025-0244},
	year = {2023},
	eissn = {2060-0399},
	pages = {43-43},
	orcid-numbers = {Maráz, Anikó/0000-0002-2018-8413; Géczi, Lajos/0000-0001-7432-2043}
}

@article{MTMT:34342976,
	title = {Miért nem kiemelkedően magas a magyar daganatos megbetegedések előfordulása? – a HUN-CONCORD vizsgálat tanulság},
	url = {https://m2.mtmt.hu/api/publication/34342976},
	author = {Kiss, Zoltán and Polgár, Csaba and Nagy, Péter and Szabó, G Tamás and Horváth, Zsolt and Wittmann, István and Molnár, Gergő Attila and Gyöngyösi, Eszter and Rokszin, György Aurél and Fábián, Ibolya and Kovács, Valéria and Abonyi-Tóth, Zsolt and Kenessey, István and Wéber, András and Branyiczkiné, Géczy Gabriella and Hilbert, Lászlóné and Bartókné, Tamás Renáta and Surján, György and Barcza, Zsófia and Gálffy, Gabriella and Bogos, Krisztina and Moldvay, Judit and Tamási, Lilla and Krasznai, Zoárd and Ostoros, Gyula and Pápai-Székely, Zsolt and Maráz, Anikó and Vokó, Zoltán},
	journal-iso = {MAGYAR ONKOLÓGIA},
	journal = {MAGYAR ONKOLÓGIA},
	volume = {67},
	unique-id = {34342976},
	issn = {0025-0244},
	year = {2023},
	eissn = {2060-0399},
	pages = {36-37},
	orcid-numbers = {Polgár, Csaba/0000-0001-7245-0762; Nagy, Péter/0000-0003-3393-235X; Abonyi-Tóth, Zsolt/0000-0002-5585-3313; Kenessey, István/0000-0002-6963-8489; Wéber, András/0000-0003-1605-8226; Maráz, Anikó/0000-0002-2018-8413}
}

@article{MTMT:34222121,
	title = {Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary},
	url = {https://m2.mtmt.hu/api/publication/34222121},
	author = {Maráz, Anikó and Nagy, Bence and Macher, Tamara and Jeskó, József and Tischler, Erika and Csongvai, Csaba and Kearney, Mairead},
	doi = {10.1007/s12325-023-02694-9},
	journal-iso = {ADV THER},
	journal = {ADVANCES IN THERAPY},
	volume = {40},
	unique-id = {34222121},
	issn = {0741-238X},
	year = {2023},
	eissn = {1865-8652},
	pages = {5475-5488},
	orcid-numbers = {Maráz, Anikó/0000-0002-2018-8413}
}

@article{MTMT:34199654,
	title = {Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study},
	url = {https://m2.mtmt.hu/api/publication/34199654},
	author = {Váradi, Melinda and Kordáné Horváth, Orsolya and Módos, Orsolya and Fazekas, Tamás and Grunewald, Camilla M and Niegisch, Günter and Krafft, Ulrich and Grünwald, Viktor and Hadaschik, Boris and Oláh, Csilla and Maráz, Anikó and Furka, Andrea and Szűcs, Miklós and Nyirády, Péter and Szarvas, Tibor},
	doi = {10.1038/s41598-023-44103-9},
	journal-iso = {SCI REP},
	journal = {SCIENTIFIC REPORTS},
	volume = {13},
	unique-id = {34199654},
	issn = {2045-2322},
	abstract = {Clinical trials revealed significant antitumor activity for immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC). Due to their strict eligibility criteria, clinical trials include selected patient cohorts, and thus do not necessarily represent real-world population outcomes. In this multicentric, retrospective study, we investigated real-world data to assess the effectiveness of pembrolizumab and atezolizumab and to evaluate the prognostic value of routinely available clinicopathological and laboratory parameters. Clinical and follow-up data from mUC patients who received ICIs (01/2017-12/2021) were evaluated. Overall survival (OS), progression-free survival (PFS), objective response rate (ORR), disease control rate (DCR), and duration of response (DOR) were used as endpoints. Patients' (n = 210, n = 76 atezolizumab and 134 pembrolizumab) median OS and PFS were 13.6 and 5.9 months, respectively. Impaired ECOG-PS, the presence of visceral, liver or bone metastases, and hemoglobin levels were independently associated with poor OS and DCR. Furthermore, Bellmunt risk factors and the enhanced Bellmunt-CRP score were shown to be prognostic for OS, PFS and DCR. In conclusion, ICIs are effective treatments for a broad range of mUC patients. Our results confirmed the prognostic value of numerous risk factors and showed that Bellmunt risk scores can further be improved when adding CRP to the model.},
	year = {2023},
	eissn = {2045-2322},
	orcid-numbers = {Váradi, Melinda/0000-0001-7733-0831; Kordáné Horváth, Orsolya/0000-0002-5456-7200; Módos, Orsolya/0000-0001-7138-8565; Maráz, Anikó/0000-0002-2018-8413; Szűcs, Miklós/0000-0003-3576-8637; Nyirády, Péter/0000-0002-7037-4919; Szarvas, Tibor/0000-0002-6321-0799}
}